Background-Nationally representative estimates oftreatment rates for congenital dislocation of the hip were required to inform a review of the current United Kingdom screening policy. Cases were ascertained through an active reporting scheme involving orthopaedic surgeons and the existing British Paediatric Association Surveillance Unit (BPASU) scheme. Objective-To report the methods used to establish, maintain, and validate the orthopaedic and BPASU schemes. As appropriate routine national sources of data for CDH are lacking,7 cases were ascertained through active reporting by consultant paediatricians and consultant orthopaedic surgeons. Reports from the former were obtained through the British Paediatric Association Surveillance Unit (BPASU) reporting scheme, established in 1985 for the surveillance of rare childhood conditions that could not be monitored through existing data collection systems.8 Paediatricians in Britain and Ireland are asked to report cases of a number of specific conditions (usually 12) seen in the preceding month on a monthly postcard, and a 90% card return rate has been reported.8 As the BPASU scheme has been used previously to determine the incidence of more common conditions such as diabetes,9 it was considered appropriate for estimating treatment rates for CDH. However, to minimise the burden of reporting for clinicians, a relatively short reporting period was chosen. Since orthopaedic surgeons treat CDH, and both consultant paediatricians and surgeons treat hip instability,2 10 a parallel orthopaedic surveillance (OS) scheme was established. This paper reports the methods used to establish and maintain the OS scheme, and the results of a study to validate the reporting bases of the BPASU and OS schemes.
Accepted 12 May 1996 In 1969, universal screening for congenital dislocation of the hip (CDH) was formally introduced in the United Kingdom' in order to detect and treat at an early stage infants who would otherwise develop established hip dislocation. The extent to which this screening programme achieves its objective is controversial,2-5 and in view of this, an MRC working party was established, at the request of the Department of Health,6 to review the current national screening policy. As part of this review, a study was initiated to obtain nationally representative estimates of rates of treatment with abduction splinting and operative procedures for CDH in children aged 5 years and under.
As appropriate routine national sources of data for CDH are lacking,7 cases were ascertained through active reporting by consultant paediatricians and consultant orthopaedic surgeons. Reports from the former were obtained through the British Paediatric Association Surveillance Unit (BPASU) reporting scheme, established in 1985 for the surveillance of rare childhood conditions that could not be monitored through existing data collection systems. 8 Paediatricians in Britain and Ireland are asked to report cases of a number of specific conditions (usually 12) seen in the preceding month on a monthly postcard, and a 90% card return rate has been reported. 8 As the BPASU scheme has been used previously to determine the incidence of more common conditions such as diabetes,9 it was considered appropriate for estimating treatment rates for CDH. However, to minimise the burden of reporting for clinicians, a relatively short reporting period was chosen. Since orthopaedic surgeons treat CDH, and both consultant paediatricians and surgeons treat hip instability,2 10 a parallel orthopaedic surveillance (OS) scheme was established. This paper reports the methods used to establish and maintain the OS scheme, and the results of a study to validate the reporting bases of the BPASU and OS schemes.
Methods

DEVELOPMENT AND MAINTENANCE OF THE ORTHOPAEDIC REPORTING BASE
In January 1993, a list of consultant orthopaedic surgeons currently practising in the United Kingdom was collated from the British Orthopaedic Association (BOA) and the British Society of Children's Orthopaedic Surgery. Surgeons were initially sent details of the study and were requested to complete and return a form indicating whether they ever treated children. A reminder letter and second form were sent after three weeks, and the secretaries of non-respondents telephoned after a further two weeks. Surgeons who treated children were eligible for inclusion in the surveillance scheme and surgeons were included if there was doubt about their eligibility. If the information was not volunteered, secretaries were asked to name any orthopaedic consultant in the department specialising in the treatment of children. New surgeons thus identified were added to the reporting base. All requests for information throughout the study could be sent to a FREEPOST address.
The reporting base was updated throughout the study period from information regarding recent consultant appointments provided by the BOA, and by monitoring advertisements for consultant orthopaedic posts in the British Reporting bases oforthopaedic and paediatric surveillance schemes Medical Journal and the Lancet. For each consultant post advertised, the relevant personnel department was contacted to ascertain whether the job description included a paediatric workload. Successful candidates for posts with an anticipated paediatric workload were subsequently contacted with details of the study and reporting scheme, and asked whether they were responsible for treating children with CDH. Those Monthly reminders were sent to surgeons not returning OS reporting cards, offering a further opportunity to state whether children with CDH were not treated. The BPASU scheme usually sends reminders to only those paediatricians with three consecutive cards outstanding but, for this study, a reminder requesting notification of children treated with abduction splinting was sent to paediatricians with one or more outstanding cards for April to July 1993. Surgeons received progress reports twice during the study period and, if appropriate, were prompted for outstanding cards and follow up forms. Regular feedback to paediatricians was provided through the BPASU quarterly bulletin.
All data were entered with a double entry system (Epi-info v.6, Atlanta). 'Smart' software (Innovative Software, 1986) was used for the databases and to track the return of cards. Data were transferred electronically between the BPASU office and the study coordinators between April and July 1993, but subsequently the latter coordinated the mailing of the orthopaedic reporting cards and data entry. VALIDATION Please report 1) The number of infants or children with CDH in whom treatment with abduction splinting was started in the last month.
2) The number of children with CDH aged 5 and under receiving a first operative procedure for CDH with or without general anaesthesia in the last month. provided as a comma delimited ASCII file. The initial cross reference was made on the basis of surname. Records with duplicate surnames were checked by hand and matched by initials. Consultant orthopaedic surgeons and paediatricians identified from the manpower censuses, but not included in the respective surveillance schemes, were sent a questionnaire to establish whether they had been a consultant at any point during the study period, whether this had been at the institution listed in the manpower census, and whether they had treated children for hip instability or CDH during this period. In addition, paediatricians were asked to identify any special interests.
PLEASE RETURN THIS CARD EVEN IF YOU HAVE NOTHING TO REPORT
Results
TARGETING OF ORTHOPAEDIC SURGEONS
The initial questionnaire was returned by 749 surgeons (69%) within three weeks of the first mailing. A total of 82% had replied two weeks after the postal reminder, leaving 194 non- reported that they had initiated treatment for hip instability during the study period specified that such children had been referred to an orthopaedic surgeon, who was included in the OS scheme. Of the paediatricians not included in the BPASU, 41% reported a special interest in community child health or neurodevelopmental assessment, and 24% in neonatology (table 2) .
Discussion
A surveillance scheme may be established to monitor the frequency of specific disorders in order to detect the early stages of an epidemic; to monitor the effectiveness of an intervention; to identify rare disorders for more detailed study; or to establish the prevalence of a condition. With the demise of regional health authorities and the reduction in the extent of routine health services data collection, voluntary surveillance schemes may assume greater importance.
There has been considerable interest internationally in the BPASU reporting scheme as a method for determining the incidence and prevalence of rare and common disorders of childhood, and several countries, including The Netherlands and Australia, have established similar schemes." Since specialists other than paediatricians are frequently involved in the diagnosis and treatment of childhood conditions, parallel reporting schemes involving other clinicians and laboratory staff have been established including obstetricians and gynaecologists for HIV surveillance,'2 neurologists for subacute sclerosing panencephalitis," ophthalmic surgeons for congenital cataract," and laboratories for Haemophilus influenzae b." In addition, dermatologists, pathologists, and rheumatologists have been included on a temporary basis in the BPASU scheme.
A key feature of the BPASU scheme is that it allows a coordinated approach8 to the surveillance of several conditions by using a single reporting card, thereby avoiding multiple contacts with paediatricians and minimising their reporting workload. It is also cost effective to resource one system which facilitates research into several conditions. In contrast, the OS scheme included only a single condition, was of limited duration, and targeted only those surgeons who ever treat children.
One measure of compliance with a scheme is the proportion of reporting cards returned. This is sometimes described as the response rate, but should perhaps be more accurately termed the card return rate, since a completed card does not guarantee a complete response in terms of the cases ascertained. The OS scheme card return rate was good, and although not as high as that for the BPASU, was higher than that of the dermatologists, pathologists and rheumatologists reporting to the BPASU, who achieved rates of 62%, 63%, and 63%
respectively." This suggests that it is possible to achieve good compliance with a reporting scheme in a relatively short period (less than three months preparation) among specialists with no prior experience of an active reporting scheme.
The initial questionnaire employed in the OS scheme allowed 708 surgeons who never treat children to be excluded. Avoiding unnecessary contact with clinicians who never treat children saved resources and potentially improved compliance. The effect of including in a surveillance scheme those clinicians who never, or only rarely, see a child with a notifiable condition may be in two directions: clinicians may have little interest in the study and neglect to make nil returns; alternatively, they may be motivated to participate, without the disincentive of requests for further information consequent on reporting a case. The former may reduce, and the latter inflate, apparent compliance without affecting case ascertainment. In either case, the card return rate may be a misleading measure The complete accuracy of any reporting scheme is not a realistic expectation. There will be imperfections of the data, but with careful monitoring of the scheme it should be possible to give at least qualitative details of these, and perhaps estimate the extent of the problem. This is essential information to provide a setting for any study findings. Details of the methods of data collection and data quality are essential to provide an informed perspective with which to view the results of a study. Multiple sources should be used to establish and maintain a complete reporting base, while respondents should be targeted if possible to avoid unnecessary workload for clinicians and save resources. Manpower census data are a potentially useful means of periodic validation for the BPASU and similar United Kingdom schemes. 
